Predominant SARS-CoV-2 variant impacts accuracy when screening for infection using exhaled breath vapor.
Written by Mitchell M McCartney, Eva Borras, Dante E Rojas, Tristan L Hicks, Katherine L Hamera, Nam K Tran, Tina Tham, Maya M Juarez, Enrique Lopez, Nicholas J Kenyon, Cristina E Davis
December 8, 2022
BACKGROUND: New technologies with novel and ambitious approaches are being developed to diagnose or screen for SARS-CoV-2, including breath tests. The US FDA approved the first breath test for COVID-19…